Full Text View
Tabular View
No Study Results Posted
Related Studies
Telemedical Interventional Monitoring in Heart Failure (TIM-HF)
This study is ongoing, but not recruiting participants.
Study NCT00543881   Information provided by Charite University, Berlin, Germany
First Received: October 11, 2007   Last Updated: November 27, 2009   History of Changes

October 11, 2007
November 27, 2009
January 2008
June 2010   (final data collection date for primary outcome measure)
Overall Mortality [ Time Frame: 1 year ]
Same as current
Complete list of historical versions of study NCT00543881 on ClinicalTrials.gov Archive Site
Days alive and out of hospital due to heart failure cardiovascular mortality sudden death overall hospitalization cardiovascular hospitalization quality of life health economics [ Time Frame: 1 year ]
Same as current
 
Telemedical Interventional Monitoring in Heart Failure
Telemedical Interventional Monitoring in Heart Failure (TIM-HF)

Superiority of additional Remote Patient Monitoring in patients with CHF In comparison to usual care in terms of:

  • reduction of mortality rate
  • reduction of hospitalizations
  • increasement of patients' quality of life

The clinical trial assesses 710 patients over a period of 15 months (January 2008 until May 2009); all participants will continue to receive usual care from their GP. All patients will be examined at the beginning of the study and will undergo a check-up every 3 months. 300 of the patients will be randomly allocated to receive devices for Remote Patient Monitoring which will measure various parameters on a daily basis (e.g., weight, blood pressure, heart rate). The devices are mobile and can be used at home or elsewhere.

Phase III
Interventional
Allocation:  Randomized
Control:  Active Control
Endpoint Classification:  Efficacy Study
Intervention Model:  Parallel Assignment
Masking:  Open Label
Primary Purpose:  Health Services Research
Chronic Heart Failure
  • Device: Remote patient monitoring (Partnership for the Heart)
    Guideline-based care in heart failure (NYHA II-III) including 5 scheduled doctor's visits plus daily monitoring of ECG, weight, blood pressure, self-report of health status, weekly monitoring of physical fitness
    Other Name: brand name for remote patient monitoring system: Partnership for the Heart
  • Device: Usual care group
    Guideline-based care in heart failure (NYHA II-III) including 5 scheduled doctor's visits
  • 1: Experimental
    Interventional group
    Intervention: Device: Remote patient monitoring (Partnership for the Heart)
  • 2: Active Comparator
    Usual care group
    Intervention: Device: Usual care group

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Active, not recruiting
710
October 2010
June 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • NYHA II-III
  • Ejection fraction < 35%
  • At least one hospitalization due to heart failure after 2006/01/01 and/or administration of iv diuretics

Exclusion Criteria:

  • Life expectancy < 1 year due to other diseases
  • Chronic renal insufficiency (Crea > 2.5 mg)
  • Mentally disabled
  • Instable angina pectoris
  • Listing for any kind of transplantation
  • Pregnancy
  • Chronic drug and/or alcohol abuse
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT00543881
 
01MG532
Charite University, Berlin, Germany
German Federal Ministry of Economics and Technology
Principal Investigator: Friedrich Koehler, MD Charité - Universitaetsmedizin Berlin
Charite University, Berlin, Germany
November 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP